In the News

FDA Eases Way for Gold-Standard Biosimilars, Law360

May 10, 2019

In an interview with Law360 about the US Food and Drug Association's recent guidance on biosimilars, Morgan Lewis partner Christopher Betti noted that, "With this final guidance, I think we are closer to seeing the first interchangeable product out there." He added, "Biosimilars have been waiting for this particular clarity before moving down a path to show interchangeability."

Read the full Law360 article >>